.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer in 2015 for an immense...
.On the heels of a period 3 win that failed to wow capitalists, Ironwood Pharmaceuticals is back alo...
.Don't cease Monte Rosa Therapies right now. The Boston-based biotech is actually enjoying after aut...
.Accept to this week's Chutes & Ladders, our summary of notable management hirings, shootings and...
.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...
.AbbVie has come back to the source of its own antipsychotic giant Vraylar searching for an addition...
.GenSight Biologics is full weeks away from lacking amount of money. Once again. The biotech merely ...
.Monopar Rehabs is actually bouncing back a medication coming from the scrap heap of AstraZeneca's u...
.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...
.After creating a gene therapy collaboration along with Dyno Therapies in 2020, Roche is back for ev...